1. S. Shibahara, F. Han, B. Li, K. Takeda, Hypoxia and heme oxygenases: oxygen sensing and regulation of expression, Antioxid. Redox Signal. 9 (2007) 2209–2225.
2. Sono, M., et al., Heme-Containing Oxygenases. Chem Rev, 1996. 96(7): p. 2841-2888.
3. Reedy, C.J. and B.R. Gibney, Heme protein assemblies. Chem Rev, 2004. 104(2): p. 617-49.
4. Antonini, E., Hemoglobin and its reaction with ligands. Science, 1967. 158(807): p. 1417-25.
5. K. Ogawa, J. Sun, S. Taketani et al., Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. The EMBO Journal, vol. 20, no. 11, pp. 2835–2843, 2001
6. M. Watanabe-Matsui, A. Muto, T. Matsui et al., Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2. Blood, vol. 117, no. 20, pp. 5438–5448, 2011.
7. Shen J, Sheng X, Chang Z, Wu Q, Wang S, Xuan Z, Li D, Wu Y, Shang Y, Kong X, Yu L, Li L, Ruan K, Hu H, Huang Y, Hui L, Xie D, Wang F, Hu R. Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function. Cell Rep. 2014 Apr 10;7(1):180-93
8. Raghuram, S., et al., Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol, 2007. 14(12):p.1207-13.
9. Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA, McKnight SL. NPAS2: A Gas-Responsive Transcription Factor. Science. 2002 Dec 20;298(5602):2385-7. Epub 2002 Nov 20.
10. S. Kumar, U. Bandyopadhyay, Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157 (2005) 175–188.
11. Immenschuh S, Vijayan V, Janciauskiene S, Gueler F. Heme as a Target for Therapeutic Interventions. Front Pharmacol. 2017 Apr 4;8:146.
12. Z. Hrkal, Z. Vodrazka, I. Kalousek, Transfer of heme from ferrihemoglobin and ferrihemoglobin isolated chains to hemopexin. Eur. J. Biochem. 43 (1974) 73–78.
13. E. Tolosano, S. Fagoonee, N. Morello, F. Vinchi, V. Fiorito, Heme scavenging and the other facets of hemopexin. Antioxid. Redox Signal. 12 (2010) 305–320.
14. V. Hvidberg,M.B.Maniecki, C. Jacobsen, P. Hojrup, H.J. Moller, S.K.Moestrup, Identification of the receptor scavenging hemopexin–heme complexes. Blood 106 (2005) 2572–2579.
15. H. Suzuki, S. Tashiro, S. Hira et al., Heme regulates gene expression by triggering Crm1‐dependent nuclear export of Bach1. The EMBO Journal, vol. 23, no. 13, p.2544–2553, 2004.
16. H. Suzuki, S. Tashiro, J. Sun, H. Doi, S. Satomi, K. Igarashi, Cadmium induces nuclear export of Bach1, a transcriptional repressor of heme oxygenase-1 gene. J. Biol. Chem. 278 (2003) 49246–49253
17. Y. Zenke-Kawasaki, Y. Dohi, Y. Katoh et al., Heme induces ubiquitination and degradation of the transcription factor Bach1. Molecular and Cellular Biology, vol. 27, no.19, pp. 6962–6971, 2007
18. M.R. Mauk, A. Smith, A.G. Mauk, An alternative view of the proposed alternative activities of hemopexin. Protein Sci. 20 (2011) 791–805.
19. T. Satoh, H. Satoh, S. Iwahara, Z. Hrkal, D.H. Peyton, U. Muller-Eberhard, Roles of heme iron-coordinating histidine residues of human hemopexin expressed in baculovirus-infected insect cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8423–8427.
20. W.W. Bakker, T. Borghuis, M.C. Harmsen, A. van den Berg, I.P. Kema, K.E. Niezen, J.J. Kapojos, Protease activity of plasma hemopexin. Kidney Int. 68 (2005) 603–610.
21. R. Lennon, A. Singh, G.I.Welsh, R.J. Coward, S. Satchell, L. Ni, P.W. Mathieson, W.W. Bakker, M.A. Saleem, Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes. J. Am. Soc. Nephrol. 19 (2008) 2140–2149.
22. S. Tsuchiya, Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, K. Tada, Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42 (1982) 1530–1536.
23. Katerina Kuzelova, Marcela Mrhalova, Zbynek Hrkal, Kinetics of heme interaction with heme-binding proteins: The effect of heme aggregation state. Biochimica et Biophysica Acta 1336 (1997). 497–501
24. E.S. Mainali, J.G. Tew, Dexamethasone selectively inhibits differentiation of cord blood stem cell derived-dendritic cell (DC) precursors into immature DCs. Cell. Immunol. 232 (2004) 127–136.
25. N. Takahashi, Y. Takahashi, F.W. Putnam, Complete amino acid sequence of human hemopexin, the heme-binding protein of serum. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 73–77.
26. N. Takahashi, Y. Takahashi, F.W. Putnam, Structure of human hemopexin: O-glycosyl and N-glycosyl sites and unusual clustering of tryptophan residues. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 2021–2025.
27. M. Horynova, K. Takahashi, S. Hall, M.B. Renfrow, J. Novak, M. Raska, Production of N-acetylgalactosaminyl-transferase 2 (GalNAc-T2) fused with secretory signal Igkappa in insect cells. Protein Expr. Purif. 81 (2012) 175–180.
28. Li X, Jiang G, Wu D, Wang X, Zeng B, Construction of a recombinant eukaryotic expression plasmid containing human calcitonin gene and its expression in NIH3T3 cells. J Biomed Biotechnol. 2009;2009:241390.
29. A.J. Dorner, L.C. Wasley, R.J. Kaufman, Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J. Biol. Chem. 264 (1989) 20602–20607.
30. S. O'Gorman, D.T. Fox, G.M. Wahl, Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251 (1991) 1351–1355.
31. M. Paoli, B.F. Anderson,H.M. Baker,W.T.Morgan, A. Smith, E.N. Baker, Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two betapropeller domains. Nat. Struct. Biol. 6 (1999) 926–931.
32. Varki A. Biological roles of glycans. Glycobiology. 2017 Jan;27(1):3-49.
33. E.A. Zemskov, I. Mikhailenko, D.K. Strickland, A.M. Belkin, Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1. J. Cell Sci. 120 (2007) 3188–3199.
34. S.K. Moestrup, J. Gliemann, G. Pallesen, Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269 (1992) 375–382.
35. Stefan W. Ryter, Jawed Alam, and Augustine M. K. Choi. Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications. Physiological Reviews 2006 86:2, 583-650
36. R.A. Fuentealba, Q. Liu, J. Zhang, T. Kanekiyo, X. Hu, J.M. Lee, M.J. LaDu, G. Bu, Lowdensity lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking. PLoS One 5 (2010) e11884.
37. L.H. Wang, K.G. Rothberg, R.G. Anderson, Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123 (1993) 1107–1117.
38. A. Rajagopal, A.U. Rao, J. Amigo, M. Tian, S.K. Upadhyay, C. Hall, S. Uhm, M.K. Mathew,M.D. Fleming, B.H. Paw,M. Krause, I.Hamza, Haemhomeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature 453 (2008) 1127–1131.
39. X. Yuan, O. Protchenko, C.C. Philpott, I. Hamza, Topologically conserved residues direct heme transport in HRG-1-related proteins. J. Biol. Chem. 287 (2012) 4914-4924.
40. Y. Ito, Y. Takeda, Analysis of glycoprotein processing in the endoplasmic reticulum using synthetic oligosaccharides. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci 88 (2012) 31–40.
41. T. Ishii, K. Itoh, E. Ruiz, D.S. Leake, H. Unoki, M. Yamamoto, G.E.Mann, Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94 (2004) 609– 616.
42. Y. Lavrovsky,M.L. Schwartzman, R.D. Levere, A. Kappas, N.G. Abraham, Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 5987–5991.
43. N. Wijayanti, S. Huber, A. Samoylenko, T. Kietzmann, S. Immenschuh, Role of NF-kappaB and p38 MAP kinase signaling pathways in the lipopolysaccharidedependent activation of heme oxygenase-1 gene expression. Antioxid. Redox Signal. 6 (2004) 802– 810.
44. Kazuhiko Igarashi, Miki Watanabe-Matsui, Wearing Red for Signaling: The Heme-Bach Axis in Heme Metabolism, Oxidative Stress Response and Iron Immunology. The Tohoku Journal of Experimental Medicine, 2014, Volume 232, Issue 4, Pages 229-253.
45. G.B. Fortes, L.S. Alves, R. de Oliveira, F.F. Dutra, D. Rodrigues, P.L. Fernandez, T. Souto-Padron,M.J. De Rosa, M. Kelliher, D. Golenbock, F.K. Chan, M.T. Bozza, Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood 119 (2012) 2368–2375.
46. C.A. Schaer, G. Schoedon, A. Imhof, M.O. Kurrer, D.J. Schaer, Constitutive endocytosis of CD163mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ. Res. 99 (2006) 943–950.
47. J. Vaysse, L. Gattegno, D. Bladier, D. Aminoff, Adhesion and erythrophagocytosis of human senescent erythrocytes by autologous monocytes and their inhibition by beta-galactosyl derivatives. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 1339–1343.
48. A. Pocivavsek, I. Mikhailenko, D.K. Strickland, G.W. Rebeck, Microglial low-density lipoprotein receptor-related protein 1modulates c-Jun N-terminal kinase activation. J. Neuroimmunol. 214 (2009) 25–32
49. T. Inubushi, A. Kawazoe, M. Miyauchi, Y. Kudo, M. Ao, A. Ishikado, T. Makino, T. Takata, Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis. J. Biol. Chem. 287 (2012) 23527–23536.
50. T. Shono, M. Ono, H. Izumi, S.I. Jimi, K. Matsushima, T. Okamoto, K. Kohno, M. Kuwano, Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol. 16 (1996) 4231–4239.
51. T. Lin, Y.H. Kwak, F. Sammy, P. He, S. Thundivalappil, G. Sun, W. Chao, H.S. Warren, Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J. Infect. Dis. 202 (2010) 624– 632.
52. F.I. Rosell, M.R. Mauk, A.G. Mauk, pH- and metal ion-linked stability of the hemopexin– heme complex. Biochemistry 44 (2005) 1872–1879.
53. White C, Yuan X, Schmidt PJ, Bresciani E, Samuel TK, Campagna D, Hall C, Bishop K, Calicchio ML, Lapierre A, Ward DM, Liu P, Fleming MD, Hamza I. HRG1 is essential for heme transport from the phagolysosome of macrophages during erythrophagocytosis. Cell Metab. 2013 Feb 5;17(2):261-70.
54. Fogarty, F., O'Keeffe, J., Zhadanov, A. et al. HRG-1 enhances cancer cell invasive potential and couples glucose metabolism to cytosolic/extracellular pH gradient regulation by the vacuolar-H+ ATPase. Oncogene 33, 4653–4663 (2014)
55. Lou Xinhan, Masafumi Matsushita, Manami Numaza, Akira Taguchi, Keiji Mitsui, and Hiroshi Kanazawa. Na+/H+ exchanger isoform 6 (NHE6/SLC9A6) is involved in clathrin-dependent endocytosis of transferrin. American Journal of Physiology-Cell Physiology 2011 301:6, C1431-C1444
56. H.J.Warnatz, D. Schmidt, T. Manke, I. Piccini, M. Sultan, T. Borodina, D. Balzereit,W. Wruck, A. Soldatov, M. Vingron, H. Lehrach, M.L. Yaspo, The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. J. Biol. Chem. 286 (2011) 23521–23532.
57. A.K. MacLeod, M. McMahon, S.M. Plummer, L.G. Higgins, T.M. Penning, K. Igarashi, J.D. Hayes, Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1–NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 30 (2009) 1571–1580.
58. F. Vinchi, L. De Franceschi, A. Ghigo, T. Townes, J. Cimino, L. Silengo, E. Hirsch, F. Altruda, E. Tolosano, Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity inmouse models of hemolytic diseases. Circulation 127 (2013) 1317–1329.
59. P. Hahl, T. Davis, C.Washburn, J.T. Rogers, A. Smith,Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states. J. Neurochem. 125 (2013) 89–101.
60. E. Tolosano, S. Fagoonee, E. Hirsch, F.G. Berger, H. Baumann, L. Silengo, F. Altruda, Enhanced splenomegaly and severe liver inflammation in haptoglobin/hemopexin double-null mice after acute hemolysis. Blood 100 (2002) 4201–4208.
61. Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, Igarashi K.,Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 2002 Oct 1;21(19):5216-24.
62. L. Jiang, M. Yin, X. Wei et al., Bach1 represses Wnt/b-catenin signaling and angiogenesis. Circulation Research, vol. 117, no. 4, pp. 364–375, 2015.
63. Wang X, Liu J, Jiang L, Wei X, Niu C, Wang R, Zhang J, Meng D, Yao K. Bach1 Induces Endothelial Cell Apoptosis and Cell-Cycle Arrest through ROS Generation. Oxid Med Cell Longev. 2016;2016:6234043. doi: 10.1155/2016/6234043.
64. Maria Angela Incalza, Rossella D'Oria, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino, Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascular Pharmacology, Volume 100(2018) 1-19
論文の公開元へ
